FDA Import Refusal SCS-9331616-8/61/1 — ABBOTT HEALTHCARE
The FDA refused shipment SCS-9331616-8/61/1 from ABBOTT HEALTHCARE (India) on Apr 14, 2025. The refused product falls under Drugs and Biologics — CEFIXIME (CEPHALOSPORINS). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Apr 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 56CCB54 CEFIXIME (CEPHALOSPORINS)
- Charges
- 75